SC 13G Filing

Company

Viridian Therapeutics, Inc.\DE

Filed

January 10, 2024

Accession Number

0000315066-24-000026

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →